Feature Channels: Vision

Filters close
Released: 30-Jul-2015 12:05 PM EDT
Researchers Resurrect Ancient Viruses in Hopes of Improving Gene Therapy
Massachusetts Eye and Ear

Researchers at Massachusetts Eye and Ear and Schepens Eye Research Institute have reconstructed an ancient virus that is highly effective at delivering gene therapies to the liver, muscle, and retina. This discovery, published July 30 in Cell Reports, could potentially be used to design gene therapies that are not only safer and more potent than therapies currently available, but may also help a greater number of patients.

Released: 28-Jul-2015 11:20 AM EDT
New Eye-Tracker Method Shows 'Preferred Retinal Location' in Both Eyes
Wolters Kluwer Health: Lippincott

Eyes with central vision loss adapt by developing a new fixation point in a different part of the retina, called the preferred retinal location (PRL). Now for the first time, a new method makes it possible to identify PRLs in both eyes simultaneously, reports a study in the August issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer.

Released: 27-Jul-2015 10:05 AM EDT
Six Reasons for Headaches in School-Age Children and How Parents Can Help Relieve the Pain
Cincinnati Children's Hospital Medical Center

As the school year approaches and begins, many parents may start to hear their children complain about headaches.

Released: 22-Jul-2015 5:15 PM EDT
Inhibition of the Alternative Complement Pathway Preserves Photoreceptor Cells Following Retinal Injury
Massachusetts Eye and Ear

Vision researchers at Massachusetts Eye and Ear/Harvard Medical School (HMS) Department of Ophthalmology have taken a first step in solving a vexing problem: how to preserve photoreceptor cells and avoid irreversible vision loss in patients following retinal detachment.

Released: 15-Jul-2015 2:05 PM EDT
Vision-Restoring Gene Therapy Also Strengthens Visual Processing Pathways in Brain
Perelman School of Medicine at the University of Pennsylvania

Since 2007, clinical trials using gene therapy have resulted in often-dramatic sight restoration for dozens of children and adults who were otherwise doomed to blindness. Now, researchers have found evidence that this sight restoration leads to strengthening of visual pathways in the brain.

Released: 2-Jul-2015 12:00 PM EDT
New Measurements Reveal Differences Between Stem Cells for Treating Retinal Degeneration
St. Jude Children's Research Hospital

By growing two types of stem cells in a “3-D culture” and measuring their ability to produce retinal cells, a team lead by St. Jude Children’s Research Hospital researchers has found one cell type to be better at producing retinal cells. The research not only reveals which stem cell type might be better for treating retinal degeneration, but it also demonstrates a standardized method for quantifying the effectiveness of different stem cells for such therapies.

29-Jun-2015 1:00 PM EDT
In Blinding Eye Disease, Trash-Collecting Cells Go Awry, Accelerate Damage
NIH, National Eye Institute (NEI)

Spider-like cells inside the brain, spinal cord and eye hunt for invaders, capturing and then devouring them. These cells, called microglia, often play a beneficial role by helping to clear trash and protect the central nervous system against infection. But a new study by researchers at the National Eye Institute (NEI) shows that they also accelerate damage wrought by blinding eye disorders, such as retinitis pigmentosa. NEI is part of the National Institutes of Health.

Released: 29-Jun-2015 9:05 AM EDT
On the Brink of Chaos: Physicists Find Phase Transition in Visual Cortex
University of Arkansas, Fayetteville

Physicists have found that intense visual input forces the brain into a brief moment of chaos, but the visual cortex spontaneously returns the brain to its optimal function.

24-Jun-2015 10:05 AM EDT
A Microtubule “Roadway” in the Retina Helps Provide Energy for Vision
The Rockefeller University Press

Researchers have discovered a thick band of microtubules in certain neurons in the retina that they believe acts as a transport road for mitochondria that help provide energy required for visual processing.

Released: 25-Jun-2015 2:05 PM EDT
Don’t Let Summer Fun Interfere with Keeping Your Peepers Protected
University of Alabama at Birmingham

Environmental factors like pool and ocean water seem harmless, but they can actually affect eye health. UAB experts break down how to stay safe this season.

Released: 24-Jun-2015 10:40 AM EDT
What's New in Contact Lenses? Prescribing Trends Reflect New Lens Materials and Designs
Wolters Kluwer Health: Lippincott

More Americans are using soft contact lenses—especially daily disposable lenses—and taking advantage of new designs targeting vision problems that were difficult to correct with previous contact lenses, reports the July issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer.

Released: 23-Jun-2015 9:05 AM EDT
How Understanding GPS Can Help You Hit a Curveball
University of Rochester

Our brains track moving objects by applying one of the algorithms your phone’s GPS uses, according to researchers at the University of Rochester. This same algorithm also explains why we are fooled by several motion-related optical illusions, including the sudden “break” of baseball’s well known “curveball illusion.”

Released: 18-Jun-2015 12:05 PM EDT
Musicians Don’t Just Hear in Tune, They Also See in Tune
Vanderbilt University

A new experiment shows that auditory melodies can enhance a musician's visual awareness of written music, particularly when the two match.

Released: 18-Jun-2015 9:05 AM EDT
Cataract Culprits
University of Delaware

When cataracts encroach on the eyes, the only effective remedy is to surgically replace the eyes' lenses with synthetic substitutes. But what if scientists found a way to delay or prevent cataracts from forming in the first place? Researchers at the University of Delaware may have found such an opportunity by identifying the prime suspects in the formation of cataracts – deficiency of two genes that encode regulatory proteins.

Released: 16-Jun-2015 5:30 PM EDT
Eye’s Motion Detection Sensors Identified
Washington University in St. Louis

Studying mice, scientists at Washington University School of Medicine in St. Louis have identified a neural circuit in the retina that carries signals enabling the eye to detect movement. The finding could help in efforts to build artificial retinas for people who have suffered vision loss.

Released: 15-Jun-2015 10:05 AM EDT
University of Iowa Driving Simulator to Help Test New Artificial Lens for Cataract Patients
University of Iowa

A miniature version of the University of Iowa’s advanced driving simulator will participate in a clinical trial later this year to assess a patient’s driving ability after cataract surgery.

10-Jun-2015 1:05 PM EDT
Virtual Reality Sheds New Light on How We Navigate in the Dark
Vanderbilt University

A series of immersive virtual reality experiments has confirmed that the human brain’s internal navigation system works in the same fashion as the grid cell system recently found in other mammals.

Released: 8-Jun-2015 3:05 PM EDT
June is Cataract Awareness Month
Mount Sinai Health System

To observe Cataract Awareness Month in June, ophthalmologists from New York Eye and Ear Infirmary of Mount Sinai (NYEE) and The Mount Sinai Hospital (MSH) – both part of the Mount Sinai Health System – are offering prevention tips and raising awareness of options for early detection and effective treatment.

Released: 2-Jun-2015 12:05 PM EDT
Trending Stories Report for 2 June 2015
Newswise Trends

Trending news releases with the most views in a single day. Topics include: melanoma, relationships, color blindness, kidney replacement, oceanography, supercomputers, awards/honors.

       
Released: 1-Jun-2015 3:00 PM EDT
New Color Blindness Cause Identified
Columbia University Irving Medical Center

A rare eye disorder marked by color blindness, light sensitivity, and other vision problems can result from a newly discovered gene mutation identified by an international research team, including scientists from Columbia University Medical Center (CUMC). The findings, which were published today in the online edition of Nature Genetics, could lead to new, targeted treatments for this form of color blindness.

Released: 1-Jun-2015 1:05 PM EDT
A World Without Color – Researchers Find Gene Mutation That Strips Color, Reduces Vision
UC San Diego Health

People with achromatopsia, an inherited eye disorder, see the world literally in black and white. Worse yet, their extreme sensitivity to light makes them nearly blind in bright sunlight. Now, researchers at University of California, San Diego School of Medicine and Shiley Eye Institute at UC San Diego Health System have identified a previously unknown gene mutation that underlies this disorder.

Released: 1-Jun-2015 11:05 AM EDT
New York Eye and Ear Infirmary of Mount Sinai Celebrates World Orthoptics Day
Mount Sinai Health System

New York Eye and Ear Infirmary of Mount Sinai (NYEE) joins with the International Orthoptic Association (IOA) to observe June 1st as World Orthoptics Day.

27-May-2015 12:05 PM EDT
Contact Lens Wearers Take Note: Your Eyes May Get More Infections Because Their "Microbiomes" Have Changed
NYU Langone Health

Using high-precision genetic tests to differentiate the thousands of bacteria that make up the human microbiome, researchers at NYU Langone Medical Center suggest that they have found a possible — and potentially surprising — root cause of the increased frequency of certain eye infections among contact lens wearers.

Released: 28-May-2015 9:05 AM EDT
The Brain’s Autofocus System Helps Stabilize Vision Despite Motion
NIH, National Eye Institute (NEI)

Much like the automatic focus of a camera, our eyes and brains must constantly recalibrate so that we can get a clear view of the changing—and always moving—world around us. Two studies funded by the National Eye Institute (NEI) show how the circuitry for this eye-brain coordination is assembled during early embryonic development.

Released: 26-May-2015 10:05 AM EDT
Trending Stories Report for 26 May 2015
Newswise Trends

Trending news releases with the most views in a single day. Topics include: genetics and cancer, diabetes and blindness, nanotech, engineering, personalized medicine, energy, and e-cigarettes.

       
20-May-2015 4:20 PM EDT
Study Suggests New Way of Preventing Diabetes-Associated Blindness
Johns Hopkins Medicine

Reporting on their study with lab-grown human cells, researchers at The Johns Hopkins University and the University of Maryland say that blocking a second blood vessel growth protein, along with one that is already well-known, could offer a new way to treat and prevent a blinding eye disease caused by diabetes.

Released: 11-May-2015 11:05 AM EDT
Study Sheds New Light on Low-Light Vision, Could Aid People with Retinal Deficits
University of California, Irvine

Driving down a dimly lit road at midnight can tax even those with 20/20 vision, but according to a recent UC Irvine study, the brain processes the experience no differently than if it were noon. The same study also reveals how quickly the brain adapts to vision loss, contradicting earlier research and opening the door to novel treatments.

Released: 11-May-2015 9:05 AM EDT
Trending Stories Report for 11 May 2015
Newswise Trends

Trending news releases with the most views in a single day. Topics include: vision research, DOE research, aging, mental health, children's health, cancer, tick-borne disease, and drone technology.

       
1-May-2015 11:05 AM EDT
Researchers Find Ebola Virus in Patient’s Eye Fluid Weeks After It Was Undetectable in Blood
Association for Research in Vision and Ophthalmology (ARVO)

On May 7, researchers are reporting a case study in which viable Ebola virus was present in the eye’s aqueous humor — the clear fluid in the front of the eye, between the lens and the cornea — 10 weeks after the virus was no longer detectable in the patient’s blood.

29-Apr-2015 2:05 PM EDT
Implant May Eliminate Need for Eye Drops After Cataract Surgery
Association for Research in Vision and Ophthalmology (ARVO)

Researchers have developed a drug-releasing implant that controls pain and inflammation, eliminating the need for eye drops following cataract surgery. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

Released: 7-May-2015 1:05 PM EDT
FDA Greenlights UCI Clinical Trial of Treatment for Blinding Disease
University of California, Irvine

A first-of-its-kind stem cell-based treatment for retinitis pigmentosa developed by UC Irvine’s Dr. Henry Klassen, Dr. Jing Yang and colleagues has received consent from the U.S. Food & Drug Administration for use in a clinical trial.

29-Apr-2015 2:05 PM EDT
New Treatment May Stop Progression of Eye Disease in Teens
Association for Research in Vision and Ophthalmology (ARVO)

Doctors have developed a new treatment capable of halting the progression of keratoconus, a progressive eye disease that manifests in teenagers. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

Released: 7-May-2015 12:05 PM EDT
Plugging in Your Vision's Autostabilization Feature
Johns Hopkins Medicine

Just like cameras with an autostabilization feature, our eyes execute an imperceptible reflex that prevents our vision from blurring when we are in motion. But before the reflex can work, the axons of specialized nerve cells must find their way from the retina to the correct part of the brain. New research describes how those axons accomplish this feat.

29-Apr-2015 2:05 PM EDT
Emerging Technique Gives Snapshot of an Individual Eye Cell’s Health
Association for Research in Vision and Ophthalmology (ARVO)

Researchers are studying ways to get a snapshot of all the genetic material that a single retina cell uses to make proteins, revealing the health of that eye cell. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

29-Apr-2015 2:05 PM EDT
FDA-Approved Drug May Prevent Vision Loss
Association for Research in Vision and Ophthalmology (ARVO)

An FDA-approved oral medication, 4-phenylbutyrate (PBA), has been found to prevent vision loss in mice with Leber’s congenital amaurosis (LCA). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

Released: 7-May-2015 8:05 AM EDT
Trending Stories Report for 7 May 2015
Newswise Trends

Trending news releases with the most views in a single day. Topics include: WWII and PTSD, stem cells, cancer, racial segregation, supplements and glaucoma, medical research, cybersecurity, vision research, and physics.

       
29-Apr-2015 2:05 PM EDT
Mobile App Helps Screen for Strabismus
Association for Research in Vision and Ophthalmology (ARVO)

Researchers have developed a mobile app to quickly and conveniently evaluate people for strabismus, a condition involving misalignment of the eyes. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

5-May-2015 4:10 PM EDT
Reasons Why Survival Rates of Extremely Premature Infants Differ by Hospital
University of Alabama at Birmingham

Between-hospital variations in active treatment explain much of the difference in survival rates seen in infants born at 22 to 24 weeks of gestation.

29-Apr-2015 2:05 PM EDT
Preterm Babies with ROP Treated with Growth Inhibitor Score Lower Than Those Treated with Laser Treatment
Association for Research in Vision and Ophthalmology (ARVO)

Preterm babies with retinopathy of prematurity (ROP) treated using bevacizumab, a growth inhibitor, have been found to have lower motor scores than babies treated with traditional laser ablation. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

29-Apr-2015 2:05 PM EDT
Nurses Help More Patients Receive Treatment for AMD
Association for Research in Vision and Ophthalmology (ARVO)

Nurses trained to deliver eye injections for patients with the wet form of age-related macular degeneration (AMD) administered the treatments as safely and effectively as doctors, according to a new study. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

29-Apr-2015 12:05 PM EDT
New Computer Model Describes Cholesterol in the Retina During AMD
Association for Research in Vision and Ophthalmology (ARVO)

Researchers have developed a new computer model to describe how cholesterol deposits, known as drusen, behave in the retina in the dry form of age-related macular degeneration (AMD). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

29-Apr-2015 2:05 PM EDT
Herbal Supplement May Successfully Treat Glaucoma
Association for Research in Vision and Ophthalmology (ARVO)

Scientists have found that baicalein significantly lowers eye pressure and may act as an all-natural treatment for glaucoma. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

29-Apr-2015 1:05 PM EDT
Scientists Develop 3D Retinal Tissue From Stem Cells Using cGMP
Association for Research in Vision and Ophthalmology (ARVO)

Scientists have produced crude 3D tissue structures from induced pluripotent stem (iPS) cells under current good manufacturing practices (cGMP), an important step for eventual large-scale use in human patients. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

29-Apr-2015 1:05 PM EDT
Parkinson’s Treatment May Protect Against AMD
Association for Research in Vision and Ophthalmology (ARVO)

L-DOPA, a routine drug taken by patients suffering from Parkinson’s disease, has been found to delay the onset of age-related macular degeneration (AMD). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

29-Apr-2015 1:05 PM EDT
New Target Identified for Treating Glaucoma
Association for Research in Vision and Ophthalmology (ARVO)

Researchers have identified a new target for stopping the progressive death of cells in the eye that leads to vision loss in glaucoma. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

29-Apr-2015 1:05 PM EDT
New Glaucoma Research May Prevent Toxins From Spreading, Save Vision
Association for Research in Vision and Ophthalmology (ARVO)

Researchers have found that blocking the connections between cells in the retina can prevent toxins in one cell from spreading – and killing – its neighbors. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Col

29-Apr-2015 1:30 PM EDT
Researchers Uncover Target for Treating Diabetic Retinopathy
Association for Research in Vision and Ophthalmology (ARVO)

Paving the way for drug discovery efforts, researchers have found a target that – when inhibited – reduces inflammation associated with vision loss in patients with diabetic retinopathy (DR). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

29-Apr-2015 1:05 PM EDT
Eyedrops as Effective as Eye Injections for Treating Wet AMD
Association for Research in Vision and Ophthalmology (ARVO)

A new study found that eye drops were just as effective as eye injections for treating the wet form of age-related macular degeneration (AMD). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

Released: 4-May-2015 5:30 PM EDT
New Biomarkers May Shorten Year-Long Diagnosis to Days
Association for Research in Vision and Ophthalmology (ARVO)

Scientists have identified new biomarkers that could distinguish Sjögren’s Syndrome (SS) from other autoimmune diseases in days or weeks, improving on a current time to diagnosis of four-plus years. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo



close
3.12165